Lowering drug prices is a political move that makes both Trump and drug companies 'look good,' says analyst

CNBC News

20 July 2018 - Increased pressure from President Trump is causing drug companies to lower prices.

Cheaper prescription drugs might seem like a good thing. But Wall Street analyst Michael Yee told CNBC that the trend of recent companies announcing they will lower or are considering lowering prices is not all it's cracked up to be.

"The important takeaway that investors should understand about the recent developments is that while there are either no price increases or in some cases, with Merck, price decreases, very interestingly, the drugs that they reduced prices on were either small drugs or very insignificant drugs," Yee, an analyst at Jefferies, said Friday.

Read CNBC News article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

Medicine , US , Regulation , Pricing